PLoS Computational BiologyGenomicsPeer-reviewed journal article
Network propagation of rare mutations in Alzheimer’s disease reveals tissue-specific hub genes and communities
Marzia A. ScelsiiD, Valerio NapolioniiD, Michael D. GreiciusiD, André AltmanniD, Alzheimer’s Disease Neuroimaging Initiative, the Alzheimer’s Disease Sequencing Project (ADSP)
Abstract
BackgroundState-of-the-art rare variant association testing methods aggregate the contribution of rare variants in biologically relevant genomic regions to boost statistical power. However, testing single genes separately does not consider the complex interaction landscape of genes, nor the downstream effects of non-synonymous variants on protein structure and function. Here we present the NETwork Propagation-based Assessment of Genetic Events (NETPAGE), an integrative approach aimed at investigating the biological pathways through which rare variation results in complex disease phenotypes.\n\nResultsWe applied NETPAGE to sporadic, late-onset Alzheimers disease (AD), using whole-genome sequencing from the AD Neuroimaging Initiative (ADNI) cohort, as well as whole-exome sequencing from the AD Sequencing Project (ADSP). NETPAGE is based on network propagation, a framework that models information flow on a graph and simulates the percolation of genetic variation through gene networks. The result of network propagation is a set of smoothed gene scores used to predict disease status through sparse regression. The application of NETPAGE to AD enabled the identification of a set of connected genes whose smoothed mutation profile acted as a robust predictor of case-control status, based on gene interactions in the hippocampus. Additionally, smoothed scores significantly correlated with risk of conversion to AD in Mild Cognitive Impairment (MCI) subjects. Lastly, we showed tissue-specific transcriptional dysregulation of the core genes in two independent RNA-seq datasets, as well as significant enrichments in terms and gene sets with known connections to AD.\n\nConclusionsThe presented framework enables enhanced genetic association testing for a wide range of traits, diseases, and sample sizes.
- organism: human
- assay: whole-genome sequencing
- assay: whole-exome sequencing
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- approach: graph neural network
- Citations
- 9
- FWCI
- 0.47
- Field percentile
- top 47%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An empirical Bayes framework for burden and dispersion association tests helps prioritize rare variants associated with Alzheimer's disease
Anjali Das, Chirag M. Lakhani, … David A. Knowles·medRxiv·Jun 25, 2026
- Alzheimer's disease variant portal (ADVP): a catalog of genetic findings for Alzheimer's disease
Pavel P. Kuksa, Chia‐Lun Liu, … Yuk Yee Leung·Journal of Alzheimer s DiseasePeer-reviewed·Jan 18, 2022
- Genome-wide prediction and integrative functional characterization of Alzheimer's disease-associated genes
Cuixiang Lin, Hong‐Dong Li, … Jianxin Wang·bioRxiv·Feb 9, 2021
- Targeted Sequencing of Alzheimers Disease Genes in Gujarat Cohort
Urvi Budhbhatti, Chaitanya G. Joshi, … Amrutlal K. Patel·bioRxiv·Apr 14, 2022
- An Integrative Network-based Analysis Reveals Gene Networks, Biological Mechanisms, and Novel Drug Targets in Alzheimer's Disease
Zachary F. Gerring, Eric R. Gamazon, … Eske M. Derks·bioRxiv·Nov 24, 2019
- Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer's disease-associated genes: DTNB and DLG2
Dmitry Prokopenko, Sanghun Lee, … Rudolph E. Tanzi·Molecular PsychiatryPeer-reviewed·Mar 4, 2022